Literature DB >> 7462586

Epidemiology of mumps in the Netherlands.

J H Wagenvoort, M Harmsen, B J Boutahar-Trouw, C A Kraaijeveld, K C Winkler.   

Abstract

In a Dutch population group neutralizing antibodies against mumps virus were determined by a plaque reduction technique, which proved reproducible, sensitive and specific. The results with sera of about 800 suburban children show that mumps is acquired at an early age with peak acquisition rates between the ages of four and six years. Over 90% have acquired mumps before the age of 14 years. More than 95% of about 1000 adults (18--65 years) have neutralizing antibodies. The relatively constant median titre suggests that antibodies persist during life. During a family study 77 clinical and 18 subclinical cases were observed. In families with index cases the attack rate was 26/37 = 0.71. Eleven children (excluding six babies) escaped infection. The mean attack rate during the epidemic was 0.30. The mean titre of mumps neutralizing antibody is maximal during the first year after the disease but declines during childhood. Mothers exposed to mumps in the family occasionally showed a significant rise in titre. Some seronegative mothers remained seronegative after exposure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7462586      PMCID: PMC2134016          DOI: 10.1017/s0022172400063385

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  16 in total

1.  Microassay of measles and mumps virus and antibody in VERO cells.

Authors:  M T Kenny; K Schell
Journal:  J Biol Stand       Date:  1975

2.  Serologic responses to para-influenza viruses in patients with mumps virus injection.

Authors:  E H LENNETTE; F W JENSEN; R W GUENTHER; R L MAGOFFIN
Journal:  J Lab Clin Med       Date:  1963-05

3.  Immunity status of military recruits in 1951 in the United States. II. Results of mumps complement-fixation tests.

Authors:  S J LIAO; A S BENENSON
Journal:  Am J Hyg       Date:  1954-05

4.  The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae.

Authors:  M K Cooney; J P Fox; C E Hall
Journal:  Am J Epidemiol       Date:  1975-06       Impact factor: 4.897

5.  Sensitive neutralization test for virus antibody. 1. Mumps antibody.

Authors:  H Sato; P Albrecht; J T Hicks; B C Meyer; F A Ennis
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

6.  [Epidemiologic and serologic analysis in mumps, with consideration of meningo-encephalitic clinical picture].

Authors:  A Stelzner; W Talaska
Journal:  Dtsch Gesundheitsw       Date:  1972-11-02

7.  A plaque neutralization test for determining mumps antibodies.

Authors:  F A Ennis; R D Douglas; G L Stewart; H E Hopps; H M Meyer
Journal:  Proc Soc Exp Biol Med       Date:  1968-12

8.  A nationwide serum survey of Brazilian military recruits, 1964. II. Antibody patterns with arboviruses, polioviruses, measles and mumps.

Authors:  J C Niederman; J R Henderson; E M Opton; F L Black; K Skvrnova
Journal:  Am J Epidemiol       Date:  1967-09       Impact factor: 4.897

9.  Mumps prophylaxis in the light of a new test for antibody.

Authors:  P P Mortimer
Journal:  Br Med J       Date:  1978-12-02

10.  STUDIES OF PARAINFLUENZA VIRUSES. II. SEROLOGIC INTERRELATIONSHIPS IN HUMANS.

Authors:  G D HSIUNG; P ISACSON; G TUCKER
Journal:  Yale J Biol Med       Date:  1963-06
View more
  8 in total

1.  Comparison of a neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of immune status of children vaccinated for mumps.

Authors:  T Harmsen; M C Jongerius; C W van der Zwan; A D Plantinga; C A Kraaijeveld; G A Berbers
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Seroepidemiological study of the transmission of the mumps virus in St. Lucia, West Indies.

Authors:  M J Cox; R M Anderson; D A Bundy; D J Nokes; J M Didier; I Simmons; J St Catherine
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

Review 3.  Advances in diagnosis and management of salivary gland diseases.

Authors:  D H Rice
Journal:  West J Med       Date:  1984-02

4.  The age of infection with varicella-zoster virus in St Lucia, West Indies.

Authors:  G P Garnett; M J Cox; D A Bundy; J M Didier; J St Catharine
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

5.  The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential impact of immunization.

Authors:  R M Anderson; J A Crombie; B T Grenfell
Journal:  Epidemiol Infect       Date:  1987-08       Impact factor: 2.451

6.  Rubella epidemiology in South East England.

Authors:  D J Nokes; R M Anderson; M J Anderson
Journal:  J Hyg (Lond)       Date:  1986-04

7.  Hemadsorption immunosorbent technique for determination of mumps immunoglobulin M antibody.

Authors:  J T van der Logt; F W Heessen; A M van Loon; J van der Veen
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

Review 8.  Molecular biology, pathogenesis and pathology of mumps virus.

Authors:  Steven Rubin; Michael Eckhaus; Linda J Rennick; Connor G G Bamford; W Paul Duprex
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.